Leon O. Moulder, Jr.
Board Member
Dianthus Therapeutics, Inc. /DE/ (DNTH)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Leon O. Moulder, Jr.
Leon O. Moulder, Jr. is recorded as Board Member and Chairman at Dianthus Therapeutics, Inc. /DE/ (DNTH). Dianthus Therapeutics, Inc. /DE/ reported in an 8-K filed May 22, 2025 that Leon O. Moulder, Jr. resigned as member of the Board of Directors, effective May 22, 2025. Dianthus Therapeutics, Inc. /DE/ reported in an 8-K filed May 28, 2024 that Leon O. Moulder, Jr. was appointed Class III director, effective May 23, 2024. Dianthus Therapeutics, Inc. /DE/ reported in an 8-K filed September 12, 2023 that Leon O. Moulder, Jr. was appointed Chair of the Board of the Directors, effective September 11, 2023. Equibles holds 4 filed executive changes naming Leon O. Moulder, Jr.; each is listed under recent activity with its source filing.
“On May 22 2025, Leon O. Moulder, Jr., a member of the Board of Directors (the "Board") of Dianthus Therapeutics, Inc. (the "Company"), notified the Company of his resignation from the Board effective immediately.”
“The Company's stockholders elected Leon O. Moulder, Jr. and Alison F. Lawton as Class III directors, to serve until the 2027 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-05-23–present
-
Current
2023-09-11–present
-
2024-05-23–2025-05-22
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Dianthus Therapeutics, Inc. /DE/
Other people whose current roles at this company are on record from its filings.
- Marino Garcia CEO, Board Member
- Alison F. Lawton Chairman
- Ryan Savitz CFO
- Steve Mahoney CFO
- Adam Veness General Counsel
- Edward Carr Chief Accounting Officer
- Anne McGeorge Board Member
- Jonathan Violin Board Member
- Jonathan Violin, Ph.D. Board Member
- Lei Meng Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.